Molly N Schieber1, Iraklis I Pipinos2, Jason M Johanning2, George P Casale3, Mark A Williams4, Holly K DeSpiegelaere5, Benjamin Senderling1, Sara A Myers6. 1. Department of Biomechanics, University of Nebraska at Omaha, Omaha, Neb. 2. Department of Surgery, Veterans' Affairs Medical Center of Nebraska and Western Iowa, Omaha, Neb; Department of Surgery, University of Nebraska Medical Center, Omaha, Neb. 3. Department of Surgery, University of Nebraska Medical Center, Omaha, Neb. 4. Department of Medicine, Creighton Univeristy, School of Medicine, Omaha, Neb. 5. Department of Surgery, Veterans' Affairs Medical Center of Nebraska and Western Iowa, Omaha, Neb. 6. Department of Biomechanics, University of Nebraska at Omaha, Omaha, Neb; Department of Surgery, Veterans' Affairs Medical Center of Nebraska and Western Iowa, Omaha, Neb. Electronic address: samyers@unomaha.edu.
Abstract
OBJECTIVE: In patients with peripheral artery disease (PAD), supervised exercise therapy is a first line of treatment because it increases maximum walking distances comparable with surgical revascularization therapy. Little is known regarding gait biomechanics after supervised exercise therapy. This study characterized the effects of supervised exercise therapy on gait biomechanics and walking distances in claudicating patients with PAD. METHODS: Forty-seven claudicating patients with PAD underwent gait analysis before and immediately after 6 months of supervised exercise therapy. Exercise sessions consisted of a 5-minute warmup of mild walking and stretching of upper and lower leg muscles, 50 minutes of intermittent treadmill walking, and 5 minutes of cooldown (similar to warmup) three times per week. Measurements included self-perceived ambulatory limitations measured by questionnaire, the ankle-brachial index (ABI), walking distance measures, maximal plantar flexor strength measured by isometric dynamometry, and overground gait biomechanics trials performed before and after the onset of claudication pain. Paired t-tests were used to test for differences in quality of life, walking distances, ABI, and maximal strength. A two-factor repeated measures analysis of variance determined differences for intervention and condition for gait biomechanics dependent variables. RESULTS: After supervised exercise therapy, quality of life, walking distances, and maximal plantar flexor strength improved, although the ABI did not significantly change. Several gait biomechanics parameters improved after the intervention, including torque and power generation at the ankle and hip. Similar to previous studies, the onset of claudication pain led to a worsening gait or a gait that was less like healthy individuals with a pain-free gait. CONCLUSIONS: Six months of supervised exercise therapy produced increases in walking distances and quality of life that are consistent with concurrent improvements in muscle strength and gait biomechanics. These improvements occurred even though the ABI did not improve. Future work should examine the benefits of supervised exercise therapy used in combination with other available treatments for PAD.
OBJECTIVE: In patients with peripheral artery disease (PAD), supervised exercise therapy is a first line of treatment because it increases maximum walking distances comparable with surgical revascularization therapy. Little is known regarding gait biomechanics after supervised exercise therapy. This study characterized the effects of supervised exercise therapy on gait biomechanics and walking distances in claudicating patients with PAD. METHODS: Forty-seven claudicating patients with PAD underwent gait analysis before and immediately after 6 months of supervised exercise therapy. Exercise sessions consisted of a 5-minute warmup of mild walking and stretching of upper and lower leg muscles, 50 minutes of intermittent treadmill walking, and 5 minutes of cooldown (similar to warmup) three times per week. Measurements included self-perceived ambulatory limitations measured by questionnaire, the ankle-brachial index (ABI), walking distance measures, maximal plantar flexor strength measured by isometric dynamometry, and overground gait biomechanics trials performed before and after the onset of claudication pain. Paired t-tests were used to test for differences in quality of life, walking distances, ABI, and maximal strength. A two-factor repeated measures analysis of variance determined differences for intervention and condition for gait biomechanics dependent variables. RESULTS: After supervised exercise therapy, quality of life, walking distances, and maximal plantar flexor strength improved, although the ABI did not significantly change. Several gait biomechanics parameters improved after the intervention, including torque and power generation at the ankle and hip. Similar to previous studies, the onset of claudication pain led to a worsening gait or a gait that was less like healthy individuals with a pain-free gait. CONCLUSIONS: Six months of supervised exercise therapy produced increases in walking distances and quality of life that are consistent with concurrent improvements in muscle strength and gait biomechanics. These improvements occurred even though the ABI did not improve. Future work should examine the benefits of supervised exercise therapy used in combination with other available treatments for PAD.
Authors: Felicity B Smith; Amanda J Lee; Jacqueline F Price; Marlene C W van Wijk; F Gerald R Fowkes Journal: J Vasc Surg Date: 2003-12 Impact factor: 4.268
Authors: Timothy P Murphy; Donald E Cutlip; Judith G Regensteiner; Emile R Mohler; David J Cohen; Matthew R Reynolds; Joseph M Massaro; Beth A Lewis; Joselyn Cerezo; Niki C Oldenburg; Claudia C Thum; Michael R Jaff; Anthony J Comerota; Michael W Steffes; Ingrid H Abrahamsen; Suzanne Goldberg; Alan T Hirsch Journal: J Am Coll Cardiol Date: 2015-03-17 Impact factor: 24.094
Authors: Melissa M Scott-Pandorf; Nicholas Stergiou; Jason M Johanning; Leon Robinson; Thomas G Lynch; Iraklis I Pipinos Journal: J Vasc Surg Date: 2007-09 Impact factor: 4.268
Authors: Panagiotis Koutakis; Iraklis I Pipinos; Sara A Myers; Nicholas Stergiou; Thomas G Lynch; Jason M Johanning Journal: J Vasc Surg Date: 2009-10-17 Impact factor: 4.268
Authors: Robert G Crowther; Warwick L Spinks; Anthony S Leicht; Kunwarjit Sangla; Frank Quigley; Jonathan Golledge Journal: J Vasc Surg Date: 2008-02 Impact factor: 4.268
Authors: Todd J Leutzinger; Panagiotis Koutakis; Matthew A Fuglestad; Hafizur Rahman; Holly Despiegelaere; Mahdi Hassan; Molly Schieber; Jason M Johanning; Nick Stergiou; G Matthew Longo; George P Casale; Sara A Myers; Iraklis I Pipinos Journal: PLoS One Date: 2022-07-13 Impact factor: 3.752
Authors: Hafizur Rahman; Iraklis I Pipinos; Jason M Johanning; George Casale; Mark A Williams; Jonathan R Thompson; Yohanis O'Neill-Castro; Sara A Myers Journal: J Vasc Surg Date: 2021-05-31 Impact factor: 4.268
Authors: Ayisha Z Bashir; Danae M Dinkel; Ganesh M Bapat; Holly Despiegelaere; Mahdi Hassan; Jason M Johanning; Iraklis I Pipinos; Sara A Myers Journal: Arch Rehabil Res Clin Transl Date: 2021-01-05
Authors: Ali Al-Ramini; Mahdi Hassan; Farahnaz Fallahtafti; Mohammad Ali Takallou; Hafizur Rahman; Basheer Qolomany; Iraklis I Pipinos; Fadi Alsaleem; Sara A Myers Journal: Sensors (Basel) Date: 2022-09-30 Impact factor: 3.847